Investor Area

Home / Investor Area / News / FDA Grants Marketing Approval For SCENESSE
 

FDA Grants Marketing Approval For SCENESSE

 

It is a privilege for CLINUVEL PHARMACEUTICALS LTD to announce the US Food & Drug Administration (FDA) has granted marketing approval to use SCENESSE® (afamelanotide 16mg) for the treatment of EPP patients in the United States. […]

Download PDF